217 related articles for article (PubMed ID: 35647914)
1.
Zhang C; Fang R; Lu X; Zhang Y; Yang M; Su Y; Jiang Y; Man C
Food Funct; 2022 Jun; 13(12):6688-6701. PubMed ID: 35647914
[TBL] [Abstract][Full Text] [Related]
2. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
3. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
4. Dietary Lactobacillus reuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism.
Lin Z; Wu J; Wang J; Levesque CL; Ma X
Food Chem; 2023 Mar; 404(Pt B):134643. PubMed ID: 36283304
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances brown adipose tissue activity and white adipose tissue browning in part by regulating bile acid metabolism via gut microbiota remodeling.
Hui S; Liu Y; Huang L; Zheng L; Zhou M; Lang H; Wang X; Yi L; Mi M
Int J Obes (Lond); 2020 Aug; 44(8):1678-1690. PubMed ID: 32203111
[TBL] [Abstract][Full Text] [Related]
6. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
7. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
[TBL] [Abstract][Full Text] [Related]
8. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility.
Wei M; Huang F; Zhao L; Zhang Y; Yang W; Wang S; Li M; Han X; Ge K; Qu C; Rajani C; Xie G; Zheng X; Zhao A; Bian Z; Jia W
EBioMedicine; 2020 May; 55():102766. PubMed ID: 32408110
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet.
Beau A; Benoit B; Le Barz M; Meugnier E; Penhoat A; Calzada C; Pinteur C; Loizon E; Chanon S; Vieille-Marchiset A; Sauvinet V; Godet M; Laugerette F; Holowacz S; Jacouton E; Michalski MC; Vidal H
Gut Microbes; 2023 Dec; 15(2):2281015. PubMed ID: 37985749
[TBL] [Abstract][Full Text] [Related]
10.
Abot A; Pomié N; Astre G; Jaomanjaka F; Marchand P; Cani PD; Roudier N; Knauf C
Int J Food Sci Nutr; 2024 Feb; 75(1):58-69. PubMed ID: 37921224
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-induced obesity requires farnesoid X receptor.
Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F
Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296
[TBL] [Abstract][Full Text] [Related]
12. Antiobesity effect of Lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in high-energy-diet-fed rats.
Chen LH; Chen YH; Cheng KC; Chien TY; Chan CH; Tsao SP; Huang HY
J Nutr Biochem; 2018 Apr; 54():87-94. PubMed ID: 29329013
[TBL] [Abstract][Full Text] [Related]
13. Treatment with camu camu (
Anhê FF; Nachbar RT; Varin TV; Trottier J; Dudonné S; Le Barz M; Feutry P; Pilon G; Barbier O; Desjardins Y; Roy D; Marette A
Gut; 2019 Mar; 68(3):453-464. PubMed ID: 30064988
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota mediates the effects of curcumin on enhancing Ucp1-dependent thermogenesis and improving high-fat diet-induced obesity.
Han Z; Yao L; Zhong Y; Xiao Y; Gao J; Zheng Z; Fan S; Zhang Z; Gong S; Chang S; Cui X; Cai J
Food Funct; 2021 Jul; 12(14):6558-6575. PubMed ID: 34096956
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
17. Limosilactobacillus reuteri and caffeoylquinic acid synergistically promote adipose browning and ameliorate obesity-associated disorders.
Liu Y; Zhong X; Lin S; Xu H; Liang X; Wang Y; Xu J; Wang K; Guo X; Wang J; Yu M; Li C; Xie C
Microbiome; 2022 Dec; 10(1):226. PubMed ID: 36517893
[TBL] [Abstract][Full Text] [Related]
18.
Zheng F; Wang Z; Stanton C; Ross RP; Zhao J; Zhang H; Yang B; Chen W
Food Funct; 2021 May; 12(9):3919-3930. PubMed ID: 33977963
[TBL] [Abstract][Full Text] [Related]
19. Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor.
Tveter KM; Villa-Rodriguez JA; Cabales AJ; Zhang L; Bawagan FG; Duran RM; Roopchand DE
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32771984
[TBL] [Abstract][Full Text] [Related]
20. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
